Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
R&D channel feed
Summit says bispecific misses overall survival in closely-watched lung cancer study
Last month
Intellia reports case of liver toxicity in ATTR gene editing study
Last month
Merck, Daiichi Sankyo scrap FDA application for HER3 ADC after survival miss
Last month
Pharma
Oric locks down cash for Phase 3 prostate cancer trial with early data in hand
Last month
PepGen ditches Duchenne programs after mid-stage fail, switches to previously halted muscle wasting therapy
Last month
The fate of Moderna’s next-gen Covid shot looms large after a flurry of policy changes
Last month
FDA+
GSK, Spero report Phase 3 win for UTI antibiotic; Spero's stock soars
Last month
Strand Therapeutics reports promising start for mRNA cancer therapy
Last month
InflaRx cans Gohibic development after skin disease trial stopped for futility
Last month
Boundless Bio changes plans for cancer drug after toxicity issues
Last month
People
Gilgamesh’s short-acting psychedelic drug shows rapid effect in Phase 2 depression study
Last month
Prothena’s amyloidosis drug flops again, spending and staff cuts are on the way
Last month
People
Kura spells out pivotal AML trial win as it gears up to compete with Syndax
Last month
Gilead notches another Phase 3 win for Trodelvy in triple-negative breast cancer
Last month
Pharma
Volastra unveils first human data of its solid tumor drug target
Last month
Merus’ Phase 2 overall survival data reach ‘home run’ scenario — analyst
Last month
Roche confirms overall survival benefit for PI3K inhibitor in breast cancer
Last month
Pharma
Jazz outlines full survival data for lung cancer drug Zepzelca
Last month
Pharma
BioNTech invests £1B in growing UK footprint under expanded pact with government
Last month
Deals
Cocaine vaccine, a longshot attempt to quell cravings, yields mixed data in small study
Last month
Genentech expands deal with molecular glue biotech Orionis for $105M upfront
Last month
Deals
How PureTech’s lung fibrosis drug stacks up against the competition
Last month
In his first major policy rollout, Vinay Prasad looks to challenge existing 'dogma' on Covid vaccines
Last month
FDA+
CRISPR Therapeutics partners with siRNA company, showing that gene editing isn’t the only answer
Last month
Cell/Gene Tx
First page
Previous page
3
4
5
6
7
8
9
Next page
Last page